| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.30 |
| The Vanguard Group, Inc. | 8.59 |
| Vanguard Group, Inc. (Subfiler) | 8.56 |
| Capital Research & Management Co. (Global Investors) | 4.56 |
| State Street Corp. | 4.22 |
| Capital Research & Management Co. (International Investors) | 3.62 |
| Vanguard Total Stock Market ETF | 3.13 |
| BlackRock Fund Advisors | 2.97 |
| Vanguard 500 Index Fund | 2.41 |
| BlackRock Institutional Trust Co. NA | 2.18 |
| Geode Capital Management LLC | 1.87 |
| Wellington Management Co. LLP | 1.80 |
| American Funds Investment Company of America | 1.30 |
| American Mutual Fund | 1.20 |
| Fidelity 500 Index Fund | 1.15 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 103'000 | 107'000 | 109'000 | 113'000 | 115'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.30 | 0.30 | 0.32 | 0.38 | 0.38 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 14'632 | 15'667 | 20'441 | 24'239 | 25'224 |
| Summe Anlagevermögen | 50'090 | 50'187 | 52'674 | 55'053 | 54'632 |
| Summe Aktiva | 67'173 | 67'887 | 72'548 | 75'196 | 74'438 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 19'566 | 19'099 | 19'890 | 19'251 | 17'946 |
| Summe Fremdkapital | 36'451 | 36'586 | 39'545 | 39'172 | 37'533 |
| Summe Eigenkapital | 30'722 | 31'301 | 33'003 | 36'024 | 36'905 |
| Summe Passiva | 67'173 | 67'887 | 72'548 | 75'196 | 74'438 |
Adresse
| 100 Abbott Park Road, 60064-6400 Abbott Park | |
| Telefon | +1 (224) 667-6100 |
| URL | http://www.abbott.com |
Management
|
Andrea F. Wainer
Executive VP-Rapid & Molecular Diagnostics |
|
Claire L. Babineaux-Fontenot
Independent Director |
|
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products |
|
Daniel J. Starks
Independent Director |
|
Darren W. McDew
Independent Director |
|
David P. Mark
Vice President-Internal Audit |
|
Gene Huang
Chief Economist & Vice President |
|
Hubert L. Allen
Secretary, Executive VP & General Counsel |
|
James R. Miller
Vice President-Marketing & Business Development |
|
Jim Leffelman
Manager-Expense Reporting |
|
John A. McCoy
Vice President & Controller |
|
John G. Stratton
Independent Director |
|
John M. Capek
Executive Vice President-Ventures |
|
Karen Chayavirabood
Regional Director-Asia |
|
Karen Peterson
Treasurer & Vice President |
|
Kathryn S. Collins
Vice President-Commercial Legal Operations |
|
Lisa D. Earnhardt
Executive Vice President-Medical Devices |
|
Mary K. Moreland
Executive Vice President-Human Resources |
|
Melissa Brotz
Vice President-Global Marketing & External Affairs |
|
Michael F. Roman
Independent Director |
|
Michael G. O'Grady
Independent Director |
|
Michelle A. Kumbier
Independent Director |
|
Nancy McKinstry
Independent Director |
|
Paola Gonzalez
Independent Director |
|
Philip P. Boudreau
Chief Financial Officer & Senior VP-Finance |
|
Randel William Woodgrift
Vice President-Global Operations & Cardiovascular |
|
Robert B. Ford
Chairman, President & Chief Executive Officer |
|
Robert Emmett Funck
Executive Vice President-Finance |
|
Robert J. Alpern
Independent Director |
|
Sally E. Blount
Independent Director |
|
Scott J. House
Senior VP-Regulatory & Engineering Services |
|
Scott Leinenweber
Vice President-Investor Relations |